Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Arthritis Society, Canada | OTHER |
| Ontario Rheumatology Association | UNKNOWN |
| Ontario Best Practices Research Initiative | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
There is accumulating evidence that early treatment leads to better outcomes for patients with inflammatory arthritis (IA). Triage, which is the process of identifying the urgency of a patient's disease state efficiently and correctly, may facilitate early referral to a rheumatologist. Several studies have suggested that placing allied health professionals (occupational therapists, physical therapists, nurses, etc.) in a triage roll may reduce wait time for patients with suspected IA. The goal of this investigation will be to demonstrate the system-level impact of an Arthritis Society extended role occupational therapist (OT) or physical therapist (PT) working in a triage role in improving access to rheumatologists for people with IA. In this study two groups will be observed: intervention and "usual care" as determined by historical chart review. Wait times will be compared between both groups.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Therapist Triage | Experimental | All subjects in this group will be triaged by an extended role occupational or physical therapist prior to their visit with the rheumatologist. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Therapist Triage | Other | An extended role occupational or physical therapist will triage each subject in the study to determine the urgency of their case and how soon they need to see the rheumatologist. |
| Measure | Description | Time Frame |
|---|---|---|
| Time to first visit with the rheumatologist (wait time) | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Time to diagnosis | 3 months | |
| Time to treatment (disease-modifying antirheumatic drug) | 3 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D015535 | Arthritis, Psoriatic |
| D013167 | Spondylitis, Ankylosing |
| D001172 | Arthritis, Rheumatoid |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D025242 | Spondylarthropathies |
| D025241 | Spondylarthritis |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D013166 |
| Spondylitis |
| D013122 | Spinal Diseases |
| D001847 | Bone Diseases |
| D011565 | Psoriasis |
| D017444 | Skin Diseases, Papulosquamous |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D000089183 | Axial Spondyloarthritis |
| D000844 | Ankylosis |
| D012216 | Rheumatic Diseases |
| D003240 | Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |